NZ511031A - A method of producing a functional immunoglobulin superfamily protein - Google Patents

A method of producing a functional immunoglobulin superfamily protein

Info

Publication number
NZ511031A
NZ511031A NZ511031A NZ51103199A NZ511031A NZ 511031 A NZ511031 A NZ 511031A NZ 511031 A NZ511031 A NZ 511031A NZ 51103199 A NZ51103199 A NZ 51103199A NZ 511031 A NZ511031 A NZ 511031A
Authority
NZ
New Zealand
Prior art keywords
protein
mhc
cell
process according
peptide
Prior art date
Application number
NZ511031A
Other languages
English (en)
Inventor
Lars Ostergaard Pedersen
Soren Buus
Original Assignee
Lars Ostergaard Pedersen
Soren Buus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lars Ostergaard Pedersen, Soren Buus filed Critical Lars Ostergaard Pedersen
Publication of NZ511031A publication Critical patent/NZ511031A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NZ511031A 1998-09-14 1999-09-14 A method of producing a functional immunoglobulin superfamily protein NZ511031A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801155 1998-09-14
PCT/DK1999/000484 WO2000015665A2 (en) 1998-09-14 1999-09-14 A method of producing a functional immunoglobulin superfamily protein

Publications (1)

Publication Number Publication Date
NZ511031A true NZ511031A (en) 2003-11-28

Family

ID=8101632

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ511031A NZ511031A (en) 1998-09-14 1999-09-14 A method of producing a functional immunoglobulin superfamily protein

Country Status (10)

Country Link
EP (1) EP1114063A2 (ja)
JP (1) JP2002524104A (ja)
KR (1) KR20010075108A (ja)
CN (1) CN1326466A (ja)
AU (1) AU771239C (ja)
BR (1) BR9914491A (ja)
CA (1) CA2343313A1 (ja)
MX (1) MXPA01002674A (ja)
NZ (1) NZ511031A (ja)
WO (1) WO2000015665A2 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2440773A1 (en) 2001-03-14 2002-09-19 Dakocytomation Denmark A/S Novel mhc molecule constructs, and methods of employing these constructs for diagnosis and therapy, and uses of mhc molecules
AU2003223936A1 (en) * 2002-05-17 2003-12-02 Kobenhavns Universitet Method for purifying denatured proteins having a desired disulfide bond configuration
US20040072262A1 (en) * 2002-10-11 2004-04-15 Montero-Julian Felix A. Methods and systems for detecting MHC class I binding peptides
WO2004072112A2 (en) * 2003-02-11 2004-08-26 Københavns Universitet A method for formulating mhc-like molecules for long time storage
JP2007526761A (ja) * 2003-10-31 2007-09-20 ヴィタテックス， インコーポレイテッド 循環性の腫瘍細胞および内皮細胞の検出のための血液試験のプロトタイプおよび方法
EP1781313A4 (en) 2004-06-17 2009-08-26 Beckman Coulter Inc MYCOBACTERIUM TUBERCULOSIS EPITOPES AND METHODS OF USE
AU2005277227B2 (en) * 2004-08-19 2011-10-06 Biogen Ma Inc. Refolding transforming growth factor beta family proteins
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
CL2007002225A1 (es) * 2006-08-03 2008-04-18 Astrazeneca Ab Agente de union especifico para un receptor del factor de crecimiento derivado de plaquetas (pdgfr-alfa); molecula de acido nucleico que lo codifica; vector y celula huesped que la comprenden; conjugado que comprende al agente; y uso del agente de un
EP2361930A3 (en) 2007-03-26 2011-10-26 Dako Denmark A/S Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
JP5583005B2 (ja) 2007-05-01 2014-09-03 バイオジェン・アイデック・エムエイ・インコーポレイテッド 血管新生を増大させるための組成物および方法
EP2167536A1 (en) 2007-07-03 2010-03-31 Dako Denmark A/S Mhc multimers, methods for their generation, labeling and use
US20090053786A1 (en) 2007-07-09 2009-02-26 Yung-Hsiang Kao Prevention of disulfide bond reduction during recombinant production of polypeptides
US10611818B2 (en) 2007-09-27 2020-04-07 Agilent Technologies, Inc. MHC multimers in tuberculosis diagnostics, vaccine and therapeutics
GB2453589A (en) 2007-10-12 2009-04-15 King S College London Protease inhibition
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
US10722562B2 (en) 2008-07-23 2020-07-28 Immudex Aps Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
CN103364558A (zh) * 2013-07-17 2013-10-23 江阴泽成生物技术有限公司 一种人肿瘤标志物癌胚抗原（cea）的磁微粒化学发光免疫分析试剂盒及其检测方法
CN109402036A (zh) * 2018-11-07 2019-03-01 河北科技师范学院 牛源肠炎沙门菌trxB基因缺失的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314813A (en) * 1992-02-19 1994-05-24 Scripps Research Institute Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
EP0640094A1 (en) * 1992-04-24 1995-03-01 The Board Of Regents, The University Of Texas System Recombinant production of immunoglobulin-like domains in prokaryotic cells
AU4923593A (en) * 1992-09-15 1994-04-12 Rockefeller University, The Major histocompatibility complex molecules and modifications thereof
EP0726777A4 (en) * 1993-10-25 2002-04-24 Anergen Inc Procarciotic expression of MHC proteins
AU3036597A (en) * 1996-05-21 1997-12-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for using peptide complexes/major histocompatibility complex to obtain or purify antigen-specific t cells and to stimulate t cells

Also Published As

Publication number Publication date
WO2000015665A3 (en) 2000-08-17
BR9914491A (pt) 2002-01-15
EP1114063A2 (en) 2001-07-11
KR20010075108A (ko) 2001-08-09
MXPA01002674A (es) 2002-06-04
AU771239C (en) 2004-10-14
WO2000015665A2 (en) 2000-03-23
JP2002524104A (ja) 2002-08-06
AU5504799A (en) 2000-04-03
CA2343313A1 (en) 2000-03-23
AU771239B2 (en) 2004-03-18
CN1326466A (zh) 2001-12-12

Similar Documents

Publication Publication Date Title
AU771239C (en) A method of producing a functional immunoglobulin superfamily protein
Garboczi et al. Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2.
JP7540948B2 (ja) ペプチド－ｍｈｃ ｃｏｍｐａｃｔ
Kelly et al. Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I‐bound determinant
US9494588B2 (en) Gene coded for a MHC class I molecule, plasmid, expression system protein, multimer, reagent and kit to analyze a T cell frequency
EP1118661A1 (en) T cell receptor libraries
Hochman et al. Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin.
AU752910B2 (en) CD8 as an inhibitor of the cellular immune system
CN114174329A (zh) 肽-mhc复合物
US11814420B2 (en) Peptide deficient-MHC class I/chaperone compositions and methods
CN113321727B (zh) 一种识别afp抗原短肽的t细胞受体及其编码序列
US20210371498A1 (en) Mhc class i compositions and methods
Strausbauch et al. Identification of mimotopes for the H4 minor histocompatibility antigen.
Peterson et al. Structural studies of β2-microglobulin-associated and other MHC antigens
Zhao et al. Expression and characterization of recombinant single-chain salmon class I MHC fused with β2-microglobulin with biological activity
Huisman et al. Shomurado a
McBerry Stable antigen presentation by single chain trimers
WO2022254200A1 (en) Peptide screen
Sgourakis High Throughput pMHC-I Tetramer Library Production Using Chaperone Mediated Peptide
Sgourakis High Throughput pMHC-I Tetramer Library Production Using Chaperone Mediated Peptide Exchange
Davis et al. TCR recognition and selection in vivo
Fan Structural studies of the human natural killer cell receptor and its MHC ligand
Duriez et al. TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange 1 catalyst 2
Miley Structural and functional exploration of classical, non-classical, and virally encoded MHC family proteins
Joseph Dna sequence analysis of t cell receptors

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: DYNAL BIOTECH ASA, NO

Free format text: OLD OWNER(S): LARS OSTERGAARD PEDERSEN; SOREN BUUS

PSEA Patent sealed
RENW Renewal (renewal fees accepted)